A Novel Fluorescent Imaging Agent for Diffuse Optical Tomography of the Breast: First Clinical Experience in Patients

PURPOSE: This is the first clinical evaluation of a novel fluorescent imaging agent (Omocianine) for breast cancer detection with diffuse optical tomography (DOT). PROCEDURES: Eleven women suspected of breast cancer were imaged with DOT at multiple time points (up to 24 h) after receiving an intrave...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: van de Ven, Stephanie, Wiethoff, Andrea, Nielsen, Tim, Brendel, Bernhard, van der Voort, Marjolein, Nachabe, Rami, Van der Mark, Martin, Van Beek, Michiel, Bakker, Leon, Fels, Lueder, Elias, Sjoerd, Luijten, Peter, Mali, Willem
Format: Artigo
Langue:Inglês
Publié: Springer-Verlag 2009
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2864903/
https://ncbi.nlm.nih.gov/pubmed/19798535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11307-009-0269-1
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires